EFX vs OGEN · P/E 54, rev $5.68B vs rev $37.7K
Equifax Inc (EFX) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the EFX and OGEN stock pages for the full models.
Not investment advice.